Dipeptidyl-peptidase IV/CD26 on T cells: Analysis of an alternative T-cell activation pathway

Immunological Reviews

Volumn 161, Issue , 1998, Pages 43-53

  Von Bonin, Arne ^a   Hühn, Jochen ^a   Fleischer, Bernhard ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; CD2 ANTIGEN; CD45 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; PROTEIN TYROSINE PHOSPHATASE; T LYMPHOCYTE RECEPTOR;

CELL SURFACE; CROSS LINKING; ENZYME ACTIVITY; HUMAN; IMMUNITY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD26; HUMANS; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 0031932784     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01570.x     Document Type: Review

References (48)

1. Fleischer B. CD26: a surface protease involved in T cell activation. Immunol Today 1994;15:180-184.
2. Morimoto C, Schlossman SF. CD26, a key costimulatory molecule on CD4 memory cells. The Immunologist 1994;2:4-7.
3. Drucker DJ, et al. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat Biotechnol 1997;15:673-677.
4. Yaron A, Naider F. Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 1993;28:31-81.
5. Brandsch M, Ganapathy V, Leibach FH. Role of dipeptidyl peptidase IV (DP IV) in intestinal and renal absorption of peptides. In: Fleischer B, ed. Dipeptidylpeptidase IV (CD26) in metabolism and the immune response. New York: Springer; 1995. p. 111-129.
6. Marguet D, Bernard AM, Vivier I, Darmoul D, Naquet P, Pierres M. cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-peptidylpeptidase IV (CD26) included in a subgroup of serine proteases. J Biol Chem 1992;267:2200-2208.
7. Lambeir AM, et al. A prediction of DPP-IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma. Biochim Biophys Acta 1997;1340:215-226.
8. Duke-Cohan JS, Morimoto C, Rocker JA, Schlossman SF. A novel form of dipeptidyl peptidase IV found in human serum. Isolation, characterisation, and comparison with T lymphocyte membrane dipeptidyl peptidase IV (CD26). J Biol Chem 1995;270:14107-14114.
9. Tanaka T, et al. Enhancement of antigen-induced T cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci USA 1994;91:3082-3086.
10. Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol 1991;147:2514-2517.
11. Dang NH, et al. Cell surface modulation of CD26 by the 1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J Immunol 1990;145:3963-3971.
12. Fleischer B, Schendel D, von Steldern D. Triggering of the lethal hit in human cytotoxic T lymphocytes: a functional role for a 103 kD T cell-specific activation antigen. Eur J Immunol 1986;16:741-746.
13. Enssle KH, Fleischer B. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis. Clin Exp Immunol 1990;79:409-415.
14. Fleischer B. A novel pathway of human T cell activation via a 103 kD T cell activation antigen. J Immunol 1987;138:1346-1350.
15. Hegen M, Niedobitek G, Klein CE, Stein H, Fleischer B. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol 1990;144:2908-2914.
16. Fleischer B, Sturm E, de Vries JE, Spits H. Triggering of cytotoxic T lymphocytes and NK cells via Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex. J Immunol 1988;141:1103-1107.
17. Plana M, et al. Induction of interleukin 2 (IL-2) and interferon-γ and enhancement of IL-2 receptor expression by a CD26 monoclonal antibody. Eur J Immunol 1991;21:1085-1088.
18. Hegen M, Camerini D, Fleischer B. Function of a transfected CD26-molecule in human T lymphocytes. Cell Immunol 1993;146:249-260.
19. Tanaka T, et al. Cloning and functional expression of the T cell activation antigen CD26. J Immunol 1992;149:481-486.
20. Schön E, et al. Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidylpeptidase IV and proliferation of human lymphocytes. Biol Chem Hoppe Seyler 1991;371:305-311.
21. Schön E, et al. The role of dipeptidylpeptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol 1987;17:1821-1826.
22. Flentke GR, Munoz E, Huber BT, Plaut AG, Kettner CA, Bachovin WW. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T cell function. Proc Natl Acad Sci USA 1991;88:1556-1559.
23. Hegen M, Mittrücker HW, Hug R, Fleischer B. Enzymatic activity of CD26 (dipeptidyl peptidase IV) is not required for its signalling function in T cells. Immunobiology 1993;189:483-493.
24. Tanaka T, Kameoka J, Yaron A, Schlossmann SF, Morimoto C. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 1993;90:4586-4590.
25. Steeg C, Hartwig U, Fleischer B. Unchanged signaling capacity of mutant CD26/Dipeptidyl peptidase IV molecules devoid of enzymatic activity. Cell Immunol 1995;164:311-315.
26. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994;76:263-274.
27. Wegener AMK, Letourneur F, Hoeveler A, Brocker T, Luton F, Malissen B. The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 1992;68:83-95.
28. Lenshow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-258.
29. Collins TL, Kassner PD, Bierer BE, Burakoff SJ. Adhesion receptors in lymphocyte activation. Curr Opin Immunol 1994;6:385-393.
30. Hegen M, Kameoka J, Dong RP, Schlossman SF, Morimoto C. Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase. Immunology 1997;90:257-264.
31. Bednarczyk JL, Carroll SM, Marin C, McIntyre BW. Triggering of the proteinase dipeptidyl peptidise IV (CD26) amplifies human T lymphocyte proliferation. J Biol Chem 1991;46:206-218.
32. Reth M. Antigen receptor due. Nature 1989;338:383-384.
33. Irving BA, Weiss A. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor associated signal transduction pathways. Cell 1991;64:891-901.
34. Klausner RD, Samelson LE. T cell antigen receptor activation pathways: the tyrosine connection. Cell 1991;64:875-878.
35. Mittrücker HW, Steeg C, Malissen B, Fleischer B. The cytoplasmic tail of the T cell receptor ζ chain is required for signaling via CD26. Eur J Immunol 1995:25:295-297.
36. Steeg C, von Bonin A, Mittrücker HW, Malissen B, Fleischer B. The cytoplasmic part of TCR-associated ζ-chain is dispensable for CD2 mediated signalling in T cell receptor expressing cells. Eur J Immunol 1997;27:2233-2238.
37. Moingeon P, et al. CD3 ζ dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells. Proc Natl Acad Sci USA 1992;39:1492-1496.
38. Donnadieu E, Trautmann A, Malissen M, Trucy J, Malissen B, Vivier E. Reconstitution of CD3 ζ coupling to calcium mobilization via genetic complementation. J Biol Chem 1994;269:32828-32834.
39. Hermans MH, Malissen B. The cytoplasmic tail of the T cell receptor ζ chain is dispensable for antigen-mediated T cell activation. Eur J Immunol 1993;23:2257-2262.
40. Carpino N, Strife A, Marshak D, Kobayashi R, Stillman B, Clarkson B. p62dok: a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997;88:197-204.
41. Yamanashi Y, Baltimore D. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 1997;88:205-211.
42. Moran MF, et al. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci USA 1990;87:8622-8626.
43. Bell GM, Fargnoli J, Bolen JB, Kisk L, Imboden JB. The SH3 domain of p56lck binds to proline-rich sequences in the cytoplasmic domain of CD2. J Exp Med 1996;183:169-178.
44. Hubert P, Lang V, Debre P, Bismuth G. Tyrosine phosphorylation and recruitment of ZAP-70 to the CD3-TCR complex are defective after CD2 stimulation. J Immunol 1996;157:4322-4332.
45. Carmo AM, Mason DW, Beyers AD. Physical association of the cytoplasmic domain of CD2 with the tyrosine kinases p56lck and p59fyn. Eur J Immunol 1993;23:2196-2201.
46. Fleischer B, ed. Dipeptidylpeptidase IV (CD26) in metabolism and the immune response. New York: Springer; 1995.
47. Subramanyam M, Gutheil WG, Bachovchin WM, Huber BT. Mechanism of HIV-1 tat induced inhibition of antigen-specific T cell responsiveness. J Immunol 1993;150:2544-2553.
48. Iwaki-Egawa S, Watanabe Y, Fujimoto Y. CD26/Dipeptidylpeptidase IV does not work as an adenosine deaminase binding protein in rat cells. Cell Immunol 1997;178:180-186.